215 filings
Page 8 of 11
8-K
e4x5tz34hsoaq8uat
13 Jul 15
Departure of Directors or Certain Officers
12:00am
8-K
z2zsxq743zkzv4ef9ij
19 Jun 15
Entry into a Material Definitive Agreement
12:00am
8-K
vu64d0js5g 8kxr6yle1
5 Jun 15
Submission of Matters to a Vote of Security Holders
12:00am
8-K
xemm6j y4xof5d8k
4 Jun 15
ChromaDex Expands Patent Rights to Pterostilbene
12:00am
8-K
ko8zs
27 May 15
Regulation FD Disclosure
12:00am
8-K
vatjats
21 May 15
Entry into a Material Definitive Agreement
12:00am
8-K
4ho448bvmvd372ai
20 Apr 15
ChromaDex Appoints Former GlaxoSmithKline Executive, Jeff Baxter, to Its Board of Directors
12:00am
8-K
ldvjj0c54h8m y77
20 Mar 15
Departure of Directors or Certain Officers
12:00am
8-K
44fp15s684cl36bit
3 Mar 15
ChromaDex® Appoints Former Nestlé Executive, Steve Allen, as Chairman
12:00am
8-K
dgxmwu 1o
11 Feb 15
Regulation FD Disclosure
12:00am
8-K
fskdqwd4exbwwu4
12 Jan 15
Regulation FD Disclosure
12:00am
8-K
mnf1vfv3enwuki17
3 Dec 14
ChromaDex® Receives $750,000 Cash from Previous Sale of its BluScience™ Line
12:00am
8-K
5bh6 vttmv
2 Dec 14
ChromaDex Licenses Exclusive Worldwide Patent Rights from the University of Mississippi for Microalgae Technology Targeting Immune Support
12:00am
8-K
xizwlc624
3 Oct 14
Entry into a Material Definitive Agreement
12:00am
8-K
6w1m4qun
30 Sep 14
ChromaDex Secures $5.0 Million in Growth Capital Financing from Hercules
12:00am
8-K
rrkzo49g6 252i2ieo62
22 Sep 14
Entry into a Material Definitive Agreement
12:00am
8-K
1edz7605mmgc jubjhu
12 Aug 14
Regulation FD Disclosure
12:00am
8-K
kpabbpc35
3 Jun 14
Entry into a Material Definitive Agreement
12:00am
8-K
ua68at9
10 Mar 14
Entry into a Material Definitive Agreement
12:00am
8-K
gm55yooe8sstmah
6 Jan 14
Departure of Directors or Certain Officers
12:00am